Staar Surgical (STAA) announced that its board of directors has appointed Warren Foust, president and COO, and Deborah Andrews, CFO, as interim co-CEOs, effective February 1. Foust and Andrews will work together with the other members of the executive leadership team as they lead the company and manage its day-to-day operations. The search committee has initiated a global search for Staar’s new CEO, including both internal and external candidates. The committee is engaging with executive search firms and evaluating interest from qualified candidates.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA:
- Seagate upgraded, Tractor Supply downgraded: Wall Street’s top analyst calls
- Staar Surgical appoints new board chair, restructures committees
- Staar Surgical resumed with an Underweight at Morgan Stanley
- Staar Surgical price target lowered to $22 from $30.75 at Canaccord
- Staar Surgical reshapes board under new investor agreement
